- Home
- DAO vs ORIC Comparison
DAO vs ORIC Comparison
Compare DAO & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAO
- ORIC
- Stock Information
- Founded
- DAO 2006
- ORIC 2014
- Country
- DAO China
- ORIC United States
- Employees
- DAO N/A
- ORIC N/A
- Industry
- DAO Other Consumer Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- DAO Real Estate
- ORIC Health Care
- Exchange
- DAO Nasdaq
- ORIC Nasdaq
- Market Cap
- DAO 1.1B
- ORIC 974.1M
- IPO Year
- DAO 2019
- ORIC 2020
- Fundamental
- Price
- DAO $8.71
- ORIC $10.88
- Analyst Decision
- DAO
- ORIC Strong Buy
- Analyst Count
- DAO 0
- ORIC 10
- Target Price
- DAO N/A
- ORIC $17.33
- AVG Volume (30 Days)
- DAO 114.7K
- ORIC 782.2K
- Earning Date
- DAO 08-14-2025
- ORIC 08-12-2025
- Dividend Yield
- DAO N/A
- ORIC N/A
- EPS Growth
- DAO N/A
- ORIC N/A
- EPS
- DAO 0.27
- ORIC N/A
- Revenue
- DAO $785,636,394.00
- ORIC N/A
- Revenue This Year
- DAO $7.25
- ORIC N/A
- Revenue Next Year
- DAO $12.88
- ORIC N/A
- P/E Ratio
- DAO $31.18
- ORIC N/A
- Revenue Growth
- DAO N/A
- ORIC N/A
- 52 Week Low
- DAO $3.00
- ORIC $3.90
- 52 Week High
- DAO $11.82
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- DAO 47.16
- ORIC 63.04
- Support Level
- DAO $8.30
- ORIC $9.87
- Resistance Level
- DAO $8.81
- ORIC $10.35
- Average True Range (ATR)
- DAO 0.37
- ORIC 0.44
- MACD
- DAO -0.07
- ORIC 0.14
- Stochastic Oscillator
- DAO 24.24
- ORIC 79.99
About DAO Youdao Inc. each representing one
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.